Objective To quantify the occurrence rate of abnormal ECG findings and symptoms following COVID-19 infection. Patients Adult patients (>18 years old) who were participating in collegiate athletics and previously tested positive for COVID-19 between August 2020 to November 2020. Methods In this retrospective study, we report findings of electrocardiogram (ECG) testing to screen athletes for cardiac abnormalities following COVID-19. Athletes underwent general examinations and ECG screening prior to being medically cleared for a return to sport following COVID-19. Predetermined predictors were grouped into categorical variables including: 1) Sex; 2) Symptom severity; and 3) BMI (normal vs. overweight = > 24 kg∙m -2 ). These were used to examine differences of abnormal rates occurred between different predictor categories. Results Of the 170 athletes screened, 6 (3.5%) presented with abnormal ECG criteria and were referred to cardiology. We found no evidence that symptom severity, sex and BMI category were associated with a higher rate of abnormal ECG ( p > 0.05). Greater severity of COVID-19 symptoms were associated with higher percentage of ST depression, T-wave inversion, ST-T changes and presence of fQRS. Loss of smell, loss of taste, headache and sore throat were the most prevalent symptoms with 32.9%, 38.8%, 36.5% and 25.3% of athletes reporting each symptom, respectively. Conclusions Preliminary findings indicate a low risk of myocardial injury secondary to COVID-19 infection with less than4% of patients presenting with abnormal ECG and 10% requiring referral to a cardiologist. While viral myocarditis was not demonstrated in any athlete referred for cardiology assessment, two patients developed effusative viral pericarditis.
Background: Dental implants have revolutionised restorative dental care but this is complex surgical and prosthodontic treatment. Excellent results have been reported in many institutional studies with a small but acceptable failure rate. It is largely unknown which of these results translate directly into a private practice setting. Methods: All patients who have dental implants placed in the maxilla by a single oral and maxillofacial surgeon in private practice in over a 3 year period were included in this study. All implants were placed in a two stage approach. All the data was collected through retrospective review of patient files and radiographic assessment. Patient data included full demographics, referral source, type and site of implants placed, and adjunctive procedures. The outcome including any complications in the first phase between placement and uncovering were recorded. The restorative phase was performed by a variety of general dentists and prosthodontists, with patients being followed up in surgical outpatients post final prostheses being issued. In all cases the individual who referred the patient and performed the reconstruction had been present at the time of surgical implantation. The outcome, including any complications in the prosthodontic reconstruction phase was recorded. This data was recorded on a standardised data sheet and maintained and analysed using SPSS (Statistical Package for the Social Sciences, version 9.05, Chicago, IL). Where two different factors were compared, the 95% confidence interval (CI) of the difference between the survival rates was calculated. A difference was considered statistically significant on a 5% level when this confidence level did not contain 0. Results: 179 mandibular implants were placed in 57 patients. On review at three years 166 (93%) were successful with 13 implant failures. Of the implants which failed, nine of them failed in the first 6 months, and none after 18 months. There were a number of trends which did not reach statistical significance. Failures were more common in the following circumstances; in the posterior mandible (11 of 13), with older mark II & III version implants (12 of 13) and implants shorter than 8 mm. There was no correlation to medical conditions or smoking. An incidental finding was a correlation between those who smoked and had heart disease. (P<0.005)
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.